Squamous cell carcinoma of the vulva: a review of present management and future considerations

References

• Cancer Stat Facts: Vulvar Cancer. Surveillance, epidemiology, and end results program; 2017 [cited 2017 Nov 8]. Available from: https://seer.cancer.gov/statfacts/html/vulva.html
   Google Scholar
• Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107(5):1018–1022.
   PubMed Web of Science ®Google Scholar
• Akhtar-Danesh N, Elit L, Lytwyn A. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study. Gynecol Oncol. 2014;134(2):314–318.
   PubMed Web of Science ®Google Scholar
• Saraiya M, Watson M, Wu X, et al. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer. 2008;113(10 Suppl):2865–2872.
   PubMed Web of Science ®Google Scholar
• Zweizig S, Korets S, Cain JM. Key concepts in management of vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):959–966.
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124(7):1626–1636.
   PubMed Web of Science ®Google Scholar
• Hoang LN, Park KJ, Soslow RA, et al. Squamous precursor lesions of the vulva: current classification and diagnostic challenges. Pathology. 2016;48(4):291–302.
   PubMed Web of Science ®Google Scholar
• Alkatout I, Schubert M, Garbrecht N, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. Int J Women’s Health. 2015;7:305–313.
   PubMed Web of Science ®Google Scholar
• Losch A, Joura EA. Vulvar neoplasia in young women. Gynecol Oncol. 1999;75(3):519.
   PubMed Web of Science ®Google Scholar
• Regauer S, Reich O. Etiology of vulvar cancer will impact on treatment options and therapy outcome: two major pathways of vulvar cancer. Gynecol Oncol. 2013;131(1):246–247.
   PubMed Web of Science ®Google Scholar
• Vanin K, Scurry J, Thorne H, et al. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J Invest Dermatol. 2002;119(5):1027–1033.
   PubMed Web of Science ®Google Scholar
• Conley LJ, Ellerbrock TV, Bush TJ, et al. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet. 2002;359(9301):108–113.
   PubMed Web of Science ®Google Scholar
• Massad LS, Silverberg MJ, Springer G, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004;190(5):1241–1248.
   PubMed Web of Science ®Google Scholar
• Rauh-Hain JA, Clemmer J, Clark RM, et al. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol. 2013;209(5):468 e461–468 e410.
   Web of Science ®Google Scholar
• Eskander RN, Baruah J, Nayak R, et al. Outside slide review in gynecologic oncology: impact on patient care and treatment. Int J Gynecol Pathol: Official J Int Society Gynecol Pathol. 2013;32(3):293–298.
   PubMed Web of Science ®Google Scholar
• HPV Vaccination; 2010 [cited 2017 Nov 14]. Available from: www.cdc.gov/vaccines/vpd-vac/hpv/.
   Google Scholar
• HPV (Human Papillomavirus) Cervarix®® VIS; 2013 [cited 2017 Nov 14]. Available from: www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv-Cervarix®.html
   Google Scholar
• Kirnbauer R, Booy F, Cheng N, et al. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A. 1992;89(24):12180–12184.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10 Suppl):3036–3046.
   PubMed Web of Science ®Google Scholar
• Wheeler CM, Kjaer SK, Sigurdsson K, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis. 2009;199(7):936–944.
   PubMed Web of Science ®Google Scholar
• Brown DR, Kjaer SK, Sigurdsson K, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis. 2009;199(7):926–935.
   PubMed Web of Science ®Google Scholar
• Naud PS, Roteli-Martins CM, De Carvalho NS, et al. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. Hum Vaccin Immunother. 2014;10(8):2147–2162.
   PubMed Web of Science ®Google Scholar
• Tabrizi SN, Brotherton JM, Kaldor JM, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012;206(11):1645–1651.
   PubMed Web of Science ®Google Scholar
• Hendry M, Lewis R, Clements A, et al. “HPV? Never heard of it!”: a systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013;31(45):5152–5167.
   PubMed Web of Science ®Google Scholar
• Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study. Cancer Causes & Control. 2003;14(9):805–814.
   PubMed Web of Science ®Google Scholar
• Tolstrup J, Munk C, Thomsen BL, et al. The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women. Acta Obstet Gynecol Scand. 2006;85(9):1114–1119.
   PubMed Web of Science ®Google Scholar
• Gunnell AS, Tran TN, Torrang A, et al. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol, Biomarkers Prev: Publ A Ass Cancer Res, Cosponsored by A Society Prev Oncol. 2006;15(11):2141–2147.
   Google Scholar
• Kirschner CV, Yordan EL, De Geest K, et al. Smoking, obesity, and survival in squamous cell carcinoma of the vulva. Gynecol Oncol. 1995;56(1):79–84.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Sedjo RL, Roe DJ, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes & Control: CCC. 2002;13(9):839–846.
   PubMed Web of Science ®Google Scholar
• Alam S, Conway MJ, Chen HS, et al. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol. 2008;82(2):1053–1058.
   PubMed Web of Science ®Google Scholar
• Boardman LA, Cooper AS, Clark M, et al. HPV, cervical neoplasia and smoking: knowledge among colposcopy patients. J Reprod Med. 2004;49(12):965–972.
   PubMed Web of Science ®Google Scholar
• Committee opinion number 503: tobacco use and women’s health. Obstet Gynecol. 2011;118(3):746–750.
   PubMedGoogle Scholar
• Santoso JT, Crigger M, English E, et al. Smoking cessation counseling in women with genital intraepithelial neoplasia. Gynecol Oncol. 2012;125(3):716–719.
   PubMed Web of Science ®Google Scholar
• Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity–a study of 350 women. Br J Dermatol. 1988;118(1):41–46.
   PubMed Web of Science ®Google Scholar
• Chan I, Oyama N, Neill SM, et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol. 2004;29(5):499–504.
   PubMed Web of Science ®Google Scholar
• Carli P, Cattaneo A, De Magnis A, et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prevention: Official J Eur Cancer Prevention Org (ECP). 1995;4(6):491–495.
   PubMed Web of Science ®Google Scholar
• Chi CC, Kirtschig G, Baldo M, et al. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011;12:Cd008240.
   PubMed Web of Science ®Google Scholar
• Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol. 1983;16(2):179–189.
   PubMed Web of Science ®Google Scholar
• Amin MB, American Joint Committee on Cancer., American Cancer Society. AJCC cancer staging manual. Eight edition/editor-in-chief, Mahul B. Amin, MD, FCAP; editors, Stephen B. Edge, MD, FACS and 16 others; Donna M. Gress, RHIT, CTR - Technical editor; Laura R. Meyer, CAPM - Managing editor. ed. Chicago IL: American Joint Committee on Cancer, Springer; 2017.
   Google Scholar
• Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104.
   PubMed Web of Science ®Google Scholar
• Homesley HD, Bundy BN, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a gynecologic oncology group study). Gynecol Oncol. 1993;49(3):279–283.
   PubMed Web of Science ®Google Scholar
• Zhou J, Shan G. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis. Curr Med Res Opin. 2016;32(6):1121–1130.
   PubMed Web of Science ®Google Scholar
• Way S, Hennigan M. The late results of extended radical vulvectomy for carcinoma of the vulva. J Obstet Gynaecol Br Commonw. 1966;73(4):594–598.
   PubMedGoogle Scholar
• Hacker NF, Barlow EL. Staging for vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2015;29(6):802–811.
   PubMed Web of Science ®Google Scholar
• Magrina JF, Gonzalez-Bosquet J, Weaver AL, et al. Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol. 2000;76(1):24–27.
   PubMed Web of Science ®Google Scholar
• Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113(4):895–901. .
   PubMed Web of Science ®Google Scholar
• Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309–314. .
   PubMed Web of Science ®Google Scholar
• Nooij LS, van der Slot MA, Dekkers OM, et al. Tumour-free margins in vulvar squamous cell carcinoma: does distance really matter? Eur J Cancer (Oxford, England: 1990). 2016;65:139–149.
   PubMed Web of Science ®Google Scholar
• Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007;104(3):636–641.
   PubMed Web of Science ®Google Scholar
• Woelber L, Eulenburg C, Choschzick M, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecoll Cancer: Official J Int Gynecol Cancer Society. 2012;22(3):503–508.
   PubMed Web of Science ®Google Scholar
• Mahner S, Jueckstock J, Hilpert F, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst. 2015;107(3).
   PubMedGoogle Scholar
• Rouzier R, Haddad B, Dubernard G, et al. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg. 2003;196(3):442–450.
   PubMed Web of Science ®Google Scholar
• Hassanzade M, Attaran M, Treglia G, et al. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013;130(1):237–245. .
   PubMed Web of Science ®Google Scholar
• Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clinical Oncology: Official J Am Soc Clin Oncol. 2008;26(6):884–889.
   PubMed Web of Science ®Google Scholar
• Te Grootenhuis NC, van der Zee AG, van Doorn HC, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen international study on sentinel nodes in vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140(1):8–14.
   PubMed Web of Science ®Google Scholar
• Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clinical Oncology: Official J Am Soc Clin Oncol. 2012;30(31):3786–3791.
   PubMed Web of Science ®Google Scholar
• Robison K, Roque D, McCourt C, et al. Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone. Gynecol Oncol. 2014;133(3):416–420.
   PubMed Web of Science ®Google Scholar
• Frey JN, Hampl M, Mueller MD, et al. Should groin recurrence still be considered as a palliative situation in vulvar cancer patients?: a brief report. Int J Gynecoll Cancer: Official J Int Gynecol Cancer Society. 2016;26(3):575–579.
   PubMed Web of Science ®Google Scholar
• Perez CA, Grigsby PW, Chao C, et al. Irradiation in carcinoma of the vulva: factors affecting outcome. Int J Radiat Oncol Biol Phys. 1998;42(2):335–344.
   PubMed Web of Science ®Google Scholar
• Perez CA, Grigsby PW, Galakatos A, et al. Radiation therapy in management of carcinoma of the vulva with emphasis on conservation therapy. Cancer. 1993;71(11):3707–3716.
   PubMed Web of Science ®Google Scholar
• Gill BS, Bernard ME, Lin JF, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a national cancer data base (NCDB) analysis. Gynecol Oncol. 2015;137(3):365–372.
   PubMed Web of Science ®Google Scholar
• Rao YJ, Chundury A, Schwarz JK, et al. Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: treatment technique and outcomes. Advances Radiat Oncol. 2017;2(2):148–158.
   PubMedGoogle Scholar
• Stecklein SR, Frumovitz M, Klopp AH, et al. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018;148(3):474–479.
   PubMed Web of Science ®Google Scholar
• Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group. Int J Radiat Oncol Biol Phys. 1998;42(1):79–85.
   PubMed Web of Science ®Google Scholar
• Forner DM, Mallmann P. Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: a pooled reanalysis. Eur J Obstet Gynecol Reprod Biol. 2017;212:115–118.
   PubMed Web of Science ®Google Scholar
• Salani R, Backes FJ, Fung MF, et al. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of gynecologic oncologists recommendations. Am J Obstet Gynecol. 2011;204(6):466–478.
   PubMed Web of Science ®Google Scholar
• Gonzalez Bosquet J, Magrina JF, Gaffey TA, et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol. 2005;97(3):828–833.
   PubMed Web of Science ®Google Scholar
• Te Grootenhuis NC, Pouwer AW, de Bock GH, et al. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review. Gynecol Oncol. 2018 Mar;148(3):622–631.
   PubMed Web of Science ®Google Scholar
• Rouzier R, Preti M, Haddad B, et al. Development and validation of a nomogram for predicting outcome of patients with vulvar cancer. Obstet Gynecol. 2006;107(3):672–677.
   PubMed Web of Science ®Google Scholar
• Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol. 2002;3(2):143–153.
   PubMedGoogle Scholar
• Binder PS, Prat J, Mutch DG. The future role of molecular staging in gynecologic cancer. Int J Gynaecol Obstet. 2015;131(Suppl 2):S127–131.
   PubMedGoogle Scholar
• Knopp S, Trope C, Nesland JM, et al. A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice. J Clin Pathol. 2009;62(3):212–218.
   PubMed Web of Science ®Google Scholar
• Obermair A, Kohlberger P, Bancher-Todesca D, et al. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol. 1996;63(2):204–209.
   PubMed Web of Science ®Google Scholar
• Bovo AC, Da Silva ID, Takita LC, et al. A comparative study of MMP-2 in vulvar neoplasms. Gynecol Oncol. 2004;93(2):454–457.
   PubMed Web of Science ®Google Scholar
• Zanvettor PH, Filho DF, Soares FA, et al. Study of biomolecular and clinical prognostic factors in patients with cancer of the vulva undergoing surgical treatment. Int J Gynecoll Cancer: Official J Int Gynecol Cancer Society. 2014;24(4):766–772.
   PubMed Web of Science ®Google Scholar